Skip to content

Epidemiology of Schizophrenia in Bulgaria

Epidemiological Study to Describe Approaches in Diagnosis, Treatment and Social Functioning of Schizophrenic Patients in Bulgaria

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00984373
Enrollment
440
Registered
2009-09-25
Start date
2009-09-30
Completion date
2009-11-30
Last updated
2010-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

Schizophrenia epidemiology, Schizophrenic patients' social and health characteristics

Brief summary

The purpose of this study is to provide accurate, reliable information on schizophrenia clinical management in order to detect unmet medical needs of this disease in terms of: * Patient characteristics. * Diagnostic and treatment approaches: initial and subsequent.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with schizophrenia * Above 18 years * Signed Informed consent

Exclusion criteria

* Below 18 years * Consent refused

Countries

Bulgaria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026